Pharmacokinetic and pharmacodynamic alterations in the geriatric patient

Consultant Pharmacist

Volumn 23, Issue 4, 2008, Pages 324-334

  Delafuente, Jeffrey C ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Adverse drug events; Aging; Pharmacodynamics; Pharmacokinetics

Indexed keywords

ALCOHOL; AMIODARONE; AMITRIPTYLINE; BENZODIAZEPINE; CARBAMAZEPINE; CELECOXIB; CHLORPROPAMIDE; CIMETIDINE; DEXTROPROPOXYPHENE; DIAZEPAM; DIGOXIN; DILTIAZEM; DIPHENHYDRAMINE; FLURAZEPAM; GLIBENCLAMIDE; LIDOCAINE; LITHIUM; MORPHINE; MUSCLE RELAXANT AGENT; OXAZEPAM; PARACETAMOL; PETHIDINE; PHENYTOIN; QUINAPRIL; RAMIPRIL; RISPERIDONE; SPASMOLYTIC AGENT; THEOPHYLLINE; UNINDEXED DRUG; VALPROIC ACID;

CLINICAL PRACTICE; CONFUSION; DELIRIUM; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG MONITORING; DRUG USE; GERIATRIC PATIENT; HEALTH CARE PERSONNEL; HUMAN; HYPOGLYCEMIA; PHARMACIST; PHARMACODYNAMICS; PHARMACOKINETICS; REVIEW; RISK FACTOR; SEDATION; SIDE EFFECT; THERAPEUTIC ERROR; URINARY EXCRETION;

EID: 44349160069     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2008.324     Document Type: Review

References (33)

1. U.S. Census Bureau, U.S. Interim Projections by Age, Sex, Race, and Hispanic Origin, 2004. Available at www.census.gov/ipc/www/usinterimproj. Accessed August 18, 2005.
2. Geriatric Medicine (Chapter 293). In: Beers MH, Berkow R, eds. The Merck Manual of Diagnosis and Therapy. 17th ed. 2005. Available at www.merck.com. Accessed August 18, 2005.
3. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990;150:841-5.
4. Gurwitz JH, Field TS, Harrold LR et al. Incidence and preventability of ADEs among older persons in the ambulatory setting. JAMA 2003;289:1107-16.
5. Hanlon JT, Schmader KE, Koronkowski MJ et al. Adverse drug events in high-risk older outpatients. J Am Geriatr Soc 1997;45:945-8.
6. Hajjar ER, Hanlon JT, Artz MB et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother 2003;1:82-9.
7. Pucino F, Beck CL, Seifert RL et al. Pharmacogeriatrics. Pharmacotherapy 1985;5:314-26.
8. Vasko MR, Brown-Cartwright D, Knochel JP et al. Furosemide absorption altered in decompensated congestive heart failure. Ann Intern Med 1985;102:314-8.
9. Newshan G. Heat-related toxicity with the fentanyl transdermal patch. J Pain Symptom Manage 1998;16:277-8 (letter).
10. Pugh CB, Garnett WR. Current issues in the treatment of epilepsy. Clin Pharm 1991;10:335-58.
11. Flockhart DA, Tanus-Santos JE. Implications of cytochrome P450 interactions when prescribing medication for hypertension. Arch Intern Med 2002;162:105-12.
12. Cusack BJ. Pharmacokinetics in older persons. Am J Geriatr Pharmacother 2004;2:274-302.
13. Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 2003;38:843-53.
14. Roberts J, Turner N. Pharmacodynamic basis for altered drug action in the elderly. Clin Geriatr Med 1988;4:127-49.
15. Chapron DJ. Drug disposition and response. In: Delafuente JC, Stewart RB, eds.Therapeutics in the Elderly. 3rd ed. Chapter 10:257-88. Cincinnati, OH: Harvey Whitney Books Co.; 2001.
16. Abernethy DR, Schwartz JB, Todd EL et al. Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients. Ann Intern Med 1986;105:329-36.
17. Platten HP, Schweizer E, Dilger K et al. Pharmacokinetics and pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction. Clin Pharmacol Ther 1998;63:552-60.
18. Beers MH, Ouslander JG, Rollingher I et al. Explicit criteria for determining inappropriate medication use in nursing homes. Arch Intern Med 1991;151:1825-32.
19. Beers MH, Ouslander JG, Fingold SF et al. Inappropriate medication prescribing in skilled nursing facilities. Ann Intern Med 1992; 117:684-9.
20. Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994;272:292-6.
21. Stuck AE, Beers MH, Steiner A et al. Inappropriate medication use in community-residing older persons. Arch Intern Med 1994;154:2195-200.
22. Golden AG, Preston RA, Barnett SD et al. Inappropriate medication prescribing in homebound older adults. J Am Geriatr Soc 1999;47:943-53.
23. Fick DM, Waller JL, Maclean JR et al. Potentially inappropriate medication use in a Medicare managed care population: association with higher costs and utilization. J Manage Care Pharm 2001;7:407-13.
24. Zhan C, Sangl J, Bierman AS et al. Potentially inappropriate medication use in the community-dwelling elderly. Findings from the 1996 Medical Expenditure Panel Survey. JAMA 2001;286:2823-9.
25. Gray SL, Hedrick SC, Rhinard EE et al. Potentially inappropriate medication use in community residential care facilities. Ann Pharmacother 2003;37:988-93
26. Curtis LH, Østbye T, Sendersky V et al. Inappropriate prescribing for elderly Americans in a large outpatient population. Arch Intern Med 2004;164:1621-5.
27. Simon SR, Chan KA, Soumerai SB et al. Potentially inappropriate medication use by elderly persons in U.S. health maintenance organizations, 2000-2001. J Am Geriatr Soc 2005;53:227-32.
28. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med 1997;157:1531-6.
29. Fick DM, Cooper JW, Wade WE et al. Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med 2003;163:2716-24.
30. Hoppmann RA, Peden JG, Ober SK. Central nervous system side effects of nonsteroidal anti-inflammatory drugs. Aseptic meningitis, psychosis, and cognitive dysfunction. Arch Intern Med 1991;151:1309-13.
31. Goodwin JS, Regan M. Cognitive dysfunction associated with naproxen and Ibuprofen in the elderly. Arthritis Rheum 1982;25:1013-5.
32. Lau DT, Kasper JD, Potter DEB et al. Hospitalization and death associated with potentially inappropriate medication prescription among elderly nursing home residents. Arch Intern Med 2005;165:68-74.
33. Perri M 3rd, Menon AM, Deshpande AD et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother 2005;39:405-11.